Page 2 - Fera Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fera pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fera Pharmaceuticals Today - Breaking & Trending Today

Patients With Serious Ophthalmologic Conditions Have Access to Phospholine Iodide®

/PRNewswire/ AllianceRx Walgreens Pharmacy has received exclusive access to Phospholine Iodide® (echothiophate iodide for ophthalmic solution) from Fera. ....

United States , Prnewswire Alliancerx Walgreens , Lisa Mymo , Adrienne Foley , Mycovia Pharmaceuticals Inc , York Heart Association , Fera Pharmaceuticals , Bristol Myers Squibb , Alliancerx Walgreens Pharmacy , Phospholine Iodide , Alliancerx Walgreens , New York Heart Association , Mycovia Pharmaceuticals , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , New Products Amp Services ,

Top GOP Rules staffer heading back to K Street- POLITICO

James Fitzella, a senior professional staffer for House Rules ranking member Tom Cole (R-Okla.), is heading back to K Street to join the Vogel Group as a director. ....

Israel General , United States , Glover Park , District Of Columbia , Carnegie Endowment For International Peace , Capitol Hill , Tom Falcone , Gump Strauss Hauer Feld , Ernestc Baynard , Lisa Scheller , Nancy Pelosi , James Fitzella , Jeff Turner , Mike Pence , David Radlo , Jack Deschauer , Daniel Lippman , Joselito Molina , Hany Farid , Katelynn Vogt , Benjamin Wofford , Sheldon Adelson , Meaghan Hohl , James Lankford , Pat Ryan , Tim Scott ,

Nicox's Partner Fera Pharmaceuticals Obtains Orphan Drug Designation from the U.S. FDA for Naproxcinod for the Treatment of Sickle Cell Disease

Press ReleaseNicox's Partner Fera Pharmaceuticals Obtains Orphan Drug Designation from the U.S. FDA for Naproxcinod for the Treatment of Sickle Cell DiseaseMarch 2nd, 2022 - release at 7:30 am CET Sophia ....

United States , Provence Alpes Côd Azur , France General , United Kingdom , Gavin Spencer , Enregistrement Universel , Pharma Bio , Kepler Cheuvreux Damien Choplain , Sophia Antipolis , Michele Garufi , Frank Dellafera , States Europe , Lifesci Advisors , Drug Administration , Head Of Corporate Development , Nicox Fera Partnership , Fera Pharmaceuticals , Eyevance Pharmaceuticals , Edison Investment Research Pooya Hemami London , Garnier Co Dylan Van Haaften Paris , Sickle Cell , Euronext Paris , Orphan Drug Designation , New Drug Application , Chief Executive Officer , Orphan Drug ,

Global Anti-Glaucoma Drug Market Top Manufacturers, Latest Innovation with Trends and Forecast 2021

Global Anti-Glaucoma Drug Market Top Manufacturers, Latest Innovation with Trends and Forecast 2021
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , South Africa , Saudi Arabia , Mark Stone , Akorn Inc , Fera Pharmaceuticals , Bausch Lomb Inc , Head Of Business Development , Teva Pharmaceuticals , Global Anti Glaucoma Drug Market , Anti Glaucoma Drug , Southeast Asia , South America , Middle East ,

Nicox Provides Fourth Quarter 2020 Business Update and Financial Highlights

Nicox Provides Fourth Quarter 2020 Business Update and Financial Highlights
Nicox Provides Fourth Quarter 2020 Business Update and Financial Highlights
Initiated two large clinical trials: Denali, the second Phase 3 of NCX 470 in glaucoma, and Mississippi, a Phase 2b of NCX 4251 in blepharitis
Phase 3 clinical trial of ZERVIATE in allergic conjunctivitis initiated by partner Ocumension Therapeutics in China
U.S. prescriptions for VYZULTA
TM by 56% over Q3 2020
Q4 2020 net revenue of €5.8 million, full year 2020 net revenue of €8.9 million and cash of €47.8 million at December 31, 2020
January 20, 2021 - release at 7:30 am CET
Sophia Antipolis, France
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today provided a business update and financial highlights for Q4 2020 for Nicox SA and its subsidiaries (the Nicox Group ), as well as key expected value-inflection milestones in 2021. ....

New York , United States , Provence Alpes Côd Azur , France General , Gavin Spencer , Kepler Cheuvreux Damien Choplain , Mary Ann Chang , Pharma Bio , Mont Blanc , Sophia Antipolis , Sophie Baumont , Cantor Fitzgerald Louise Chen , States Europe , Garnier Co Victor Floch Paris , Santen Pharmaceutical Co Ltd Of Japan , Nicox Group , European Patent Office , Lifesci Advisors , Head Of Corporate Development , Fera Pharmaceuticals , Eyevance Pharmaceuticals , Oppenheimer Co Hartaj Singh New York , Santen Holdings Us Inc , Provides Fourth Quarter , Ocumension Therapeutics , Euronext Paris ,